CS MEDICA
CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024
REG
CS MEDICA A/S, a MedTech company that focuses on treating pain, autoimmune diseases, and stress-related disorders with therapeutic CBD/cannabinoids, announces the rescheduling of its Annual Report to Wednesday, February 14, 2024. Consequently, the Annual General Meeting is also rescheduled and will now occur on Thursday, February 29, 2024.
Datum | 2023-11-29, kl 11:52 |
Källa | Cision |
![](https://static.allaaktier.se/ads/avanza_inverted.png)
Investeringar innebär en risk